Cytokinetics (CYTK) Operating Leases (2018 - 2026)
Cytokinetics (CYTK) posted Operating Leases of $99.67 million for Q3 2026, down 9.9% from $110.66 million a year earlier and down 2.7% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Operating Leases (2018 - 2026) Analysis & Trends
At the end of FY2025, Cytokinetics' Operating Leases came in at $107.97 million, down 4.1% from FY2024.
- Annual Operating Leases has declined for three consecutive years, though with a five-year compound annual growth rate of 200.6% (FY2020 to FY2025).
- In prior years, Cytokinetics' Operating Leases was $112.58 million in FY2024 (-6.5%), $120.43 million in FY2023 (-5.1%), $126.9 million in FY2022 (+13.1%) and $112.23 million in FY2021.
- The Q3 2026 figure stands as the lowest quarterly Operating Leases since Q1 2021.
- On a year-over-year basis, Operating Leases has declined in each of the last 12 quarters, with an average decline of 6.0% over the last eight quarters.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q1 2022, with growth of 30.8%; the weakest was Q3 2026, with a decline of 9.9%.
- According to Business Quant data, Operating Leases for the three prior quarters was $102.43 million (Q2 2026), $105.24 million (Q1 2026) and $107.97 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Cytokinetics | 7.81 Bn | 3.81 Bn | 47.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 99.67 Mn |
| Jun 30, 2026 | 102.43 Mn |
| Mar 31, 2026 | 105.24 Mn |
| Dec 31, 2025 | 107.97 Mn |
| Sep 30, 2025 | 110.66 Mn |
| Jun 30, 2025 | 111.03 Mn |
| Mar 31, 2025 | 113.35 Mn |
| Dec 31, 2024 | 112.58 Mn |
| Sep 30, 2024 | 114.75 Mn |
| Jun 30, 2024 | 116.72 Mn |
| Mar 31, 2024 | 118.55 Mn |
| Dec 31, 2023 | 120.43 Mn |
| Sep 30, 2023 | 122.22 Mn |
| Jun 30, 2023 | 123.83 Mn |
| Mar 31, 2023 | 125.34 Mn |
| Dec 31, 2022 | 126.90 Mn |
| Sep 30, 2022 | 114.41 Mn |
| Jun 30, 2022 | 112.73 Mn |
| Mar 31, 2022 | 112.02 Mn |
| Dec 31, 2021 | 112.23 Mn |
API Access
Cytokinetics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();